NOVALAKA
NovaLaka is a technological innovator of slow release drug delivery systems in the drug delivery market focused on the transmucosal route and specialising in female healthcare. The idea behind the technology arose from the glaucoma research supervised by NovaLaka's cofounders at the Jerusalem College of Engineering in Israel. NovaLaka participated in round two of AtoBe's accelerator. Subsequently supported by the Israel Innovation Authority, NovaLaka now cooperates with numerous institu... tions including Hadassah Hospital. We have developed an easy to apply smart polymeric substance, that is applied directly to the skin, in the treatment of vaginal dryness. Our easy-to-adminster biofilm is applied directly to the affected area and provides immediate and prolonged release of our moisturising gel. NovaLaka's innovation and development provides additional exciting opportunities in transmucosal and transdermal routes for drug delivery.
NOVALAKA
Industry:
Biotechnology Health Care Personal Health Pharmaceutical Wellness Women's
Founded:
2015-10-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.novalaka.com
Total Employee:
1+
Status:
Closed
Contact:
+972523684252
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
Similar Organizations
LUÜNA
Thoughtful products & programs designed to close the gender health gap in Asia.
Souvie Biodelivery
Souvie Biodelivery develops drug delivery services with the goal of marketing novel drug delivery platforms to drug delivery niche markets.
Current Employees Featured
Founder
Newest Events participated
Participated in Wolves Summit
on 2020-04-30 as contestant
More informations about "NovaLaka"
NovaLaka - Crunchbase Company Profile & Funding
NovaLaka is a technological innovator of slow release drug delivery systems in the drug delivery market focused on the transmucosal route and specialising in female healthcare. The idea …See details»
NovaLaka - LinkedIn
NovaLaka was established in 2015 as an initiative of dynamic and innovative graduates who recognize the need for the improvement of treatments, technology and research in the field …See details»
NovaLaka - Slow-release Transmucosal Drug Delivery Systems
Jun 21, 2017 · NovaLaka develops technology in the field of slow-release drug-delivery systems, specializing in transmucosal solutions for women's healthcare applications. The company has …See details»
NovaLaka - Contacts, Employees, Board Members, Advisors
NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery marketSee details»
NovaLaka - F6S
Pharmaceutical R&D company - Polymers slow release technology. NovaLaka is a technological innovator of slow release drug delivery systems in the drug delivery market focused on the …See details»
NovaLaka - Funding, Financials, Valuation & Investors - Crunchbase
May 20, 2017 · NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery marketSee details»
NovaLaka | ConnectAmericas
NovaLaka develops technology in the field of slow-release drug delivery systems, specializing in transmucosal solutions for use in female healthcare applications. The company has developed …See details»
Eva Avrina, Chief Executive Officer working at Novalaka
Chief Executive Officers are responsible for making sure that their organization meets its goals and objectives through strategic planning and execution. Also known as Chief Operating …See details»
JLM based Novolaka from AtoBe won first place at the Global …
Jul 15, 2017 · Novalaka won first place from the 120 medical start-ups that presented. NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery market.See details»
NovaLaka - Tech Stack, Apps, Patents & Trademarks - Crunchbase
NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery marketSee details»
Eva Zofia Avrina | NovaLaka Pharmaceuticals | Israel - OMICS …
Her focus in NovaLaka is on promoting women in science and entrepreneurship, developing contacts with investors and partners, as well as overseeing the marketing activities of the …See details»
NovaLaka - We are happy to announce that NovaLaka has won.
Jun 27, 2017 · We are happy to announce that NovaLaka has won the 1st prize out of 120 companies and startups from China, Japan, Taiwan, Hong Kong, Singapore, Israel and the …See details»
JLM based Novolaka from AtoBe won first place at the Global …
Jul 15, 2017 · Novalaka won first place from the 120 medical start-ups that presented. NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery …See details»
NovaLaka | ConnectAmericas
NovaLaka develops technology in the field of slow-release drug delivery systems, specializing in transmucosal solutions for use in female healthcare applications. The company has developed …See details»
Eva Avrina - CEO, Co-Founder @ NovaLaka - Crunchbase
Eva has been working in business development in international settings for over 10 years, developing networks and partnerships with industries, governments and academia in Europe, …See details»
NovaLaka - Facebook
NovaLaka leads the future of Polymer Slow Release technology in various different health and medicin.See details»
NovaLaka - Lifecycle | Startup Nation Finder
Find out more about NovaLaka's lifecycle at SNC Finder! Explore the company's timeline including investment rounds, public offerings, M&A and more.See details»
Log in to your Okta org
Not yet an Okta customer? If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, …See details»
NovaLaka - Crunchbase
NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery marketSee details»
List of House of Cards (American TV series) characters
House of Cards is an American political drama web television series created by Beau Willimon for Netflix.It is an adaptation of the BBC's miniseries of the same name and is based on the 1989 …See details»